AβPP-overexpression and proteasome inhibition increase αB-crystallin in cultured human muscle: Relevance to inclusion-body myositis

Neuromuscular Disorders

Volumn 16, Issue 12, 2006, Pages 839-844

  Wojcik, Slawomir ^a   Engel, W King ^a   McFerrin, Janis ^a   Paciello, Orlando ^a   Askanas, Valerie ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

B Crystallin; Amyloid ; Amyloid precursor protein; Cultured human muscle fibers; Inclusion body myositis

Indexed keywords

ALPHA CRYSTALLIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; EPOXOMICIN; OLIGOMER; PROTEASOME; OLIGOPEPTIDE;

ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INCLUSION BODY MYOSITIS; MUSCLE BIOPSY; MUSCLE FIBER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; CELL CULTURE; CELL INCLUSION; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; STRESS; UPREGULATION;

ALPHA-CRYSTALLIN B CHAIN; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; INCLUSION BODIES; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; OLIGOPEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; STRESS; UP-REGULATION;

EID: 33845217281     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2006.08.009     Document Type: Article

References (32)

1. Engel W.K., and Askanas V. Inclusion-body myositis: clinical, diagnostic, and pathologic aspects. Neurology 66 (2006) S20-S29
2. Askanas V., and Engel W.K. Inclusion-body myositis. A myodegenerative conformational disorder associated with Aβ, protein misfolding, and proteasome inhibition. Neurology 66 (2006) S39-S48
3. Dalakas M.C. Inflammatory, immune, and viral aspects of inclusion-body myositis. Neurology 66 (2006) S33-S38
4. Fratta P., Engel W.K., McFerrin J., Davies K.J., Lin S.W., and Askanas V. Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers. Am J Pathol 167 (2005) 517-526
5. Askanas V., McFerrin J., Baque S., Alvarez R.B., Sarkozi E., and Engel W.K. Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc Natl Acad Sci USA 93 (1996) 1314-1319
6. Askanas V., McFerrin J., Alvarez R.B., Baque S., and Engel W.K. βAPP gene transfer into cultured human muscle induces inclusion-body myositis aspects. Neuroreport 8 (1997) 2155-2158
7. McFerrin J., Engel W.K., and Askanas V. Impaired innervation of cultured human muscle overexpressing βAPP experimentally and genetically: Relevance to inclusion-body myopathies. Neuroreport 9 (1998) 201-205
8. Jin L.W., Hearn M.G., Ogburn C.E., et al. Transgenic mice over-expressing the C-99 fragment of AβPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis. Am J Pathol 153 (1998) 1679-1686
9. Fukuchi K., Pham D., Hart M., Li L., and Lindsey J.R. Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy. Am J Pathol 153 (1998) 1687-1693
10. Sugarman M.C., Yamasaki T.R., Oddo S., et al. Inclusion body myositis-like phenotype induced by transgenic overexpression of bAPP in skeletal muscle. Proc Natl Acad Sci USA 99 (2002) 6334-6339
11. Askanas V., Engel W.K., McFerrin J., and Vattemi G. Transthyretin Val122Ile, accumulated Aβ and inclusion-body myositis aspects in cultured muscle. Neurology 22 61 (2003) 257-260
12. Klein W.L. ADDLs and protofibrils: the missing links?. Neurobiol Aging 23 (2002) 231-235
13. Walsh D.M., Klyubin I., Fadeeva J.V., et al. Naturally secreted oligomers of amyloid-β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
14. Dahlgren K.N., Manelli A.M., Stine Jr. W.B., Baker L.K., Krafft G.A., and LaDu M.J. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277 (2002) 32046-32053
15. De Felice F.G., Vieira M.N., Saraiva L.M., et al. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization. FASEB J 18 (2004) 1366-1372
16. Watson D., Castano E., Kokjohn T.A., et al. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease. Neurol Res 27 (2005) 869-881
17. Banwell B.L., and Engel A.G. αB-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology 54 (2000) 1033-1041
18. Karpati G., and Hohlfeld R. Biologically stressed muscle fibers in sporadic IBM: a clue for the enigmatic etiology?. Neurology 14 54 (2000) 1020-1021
19. Derham B.K., and Harding J.J. Alpha-crystallin as a molecular chaperone. Prog Retin Eye Res 18 (1999) 463-509
20. Yu S., and MacRae T.H. The small heat shock proteins and their role in human disease. FEBS Journal 272 (2005) 2613-2627
21. Askanas V., and Engel W.K. Cultured normal and genetically abnormal human muscle. In: Rowland L.P., and Di Mauro S. (Eds). The Handbook of Clinical Neurology, Myopathies vol. 18 (1992), North Holland, Amsterdam 85-116
22. Meng L., Mohan R., Kwok B.H., Elofsson M., Sin N., and Crews C.M. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci USA 96 (1999) 10403-10408
23. Vattemi G., Engel W.K., McFerrin J., and Askanas V. Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles. J Neurochem 85 (2003) 1539-1546
24. Vattemi G., Engel W.K., McFerrin J., and Askanas V. Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. Am J Pathol 164 (2004) 1-7
25. Wojcik S., Engel W.K., McFerrin J., and Askanas V. Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers. Acta Neuropathol (Berl) 110 (2005) 173-177
26. Cottrell B.A., Galvan V., Banwait S., et al. A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease. Ann Neurol 58 (2005) 277-289
27. Raman B., Ban T., Sakai M., et al. αB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid-β peptide and beta2 microglobulin. Biochem J 392 (2005) 573-581
28. Stege G.J., Renkawek K., Overkamp P.S., et al. The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity. Biochem Biophys Res Commun 262 (1999) 152-156
29. Boros S., Kamps B., Wunderink L., de Bruijin W., de Jong W.W., and Boelens W.C. Transglutaminase catalyzes differential crosslinking of small heat shock proteins and amyloid-β. FEBS Lett 576 (2004) 57-62
30. Vicart P., Caron A., Guicheney P., et al. A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet 20 (1998) 92-95
31. Sanbe A., Osinska H., Villa C., et al. Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. Proc Natl Acad Sci USA 102 (2005) 13592-13597
32. Ito H., Kamei K., Iwamoto I., et al. Inhibition of proteasomes induces accumulation, phosphorylation, and recruitment of HSP27 and alphaB-crystallin to aggresomes. J Biochem (Tokyo) 131 (2002) 593-603